Comparison of the pharmacokinetics and tolerability of HCP1004 (a fixed-dose combination of naproxen and esomeprazole strontium) and VIMOVO® (a marketed fixed-dose combination of naproxen and esomeprazole magnesium) in healthy volunteers
Keyword(s):
2014 ◽
Vol 34
(5)
◽
pp. 335-349
◽
Keyword(s):
2008 ◽
Vol 24
(6)
◽
pp. 1703-1709
◽
Keyword(s):
Keyword(s):
2012 ◽
Vol 52
(5)
◽
pp. 670-680
◽
Keyword(s):
2016 ◽
Vol 24
(4)
◽
pp. 175
◽
Keyword(s):